Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 11:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 3,553 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fluids Clear all

Conditions: Diabetes Mellitus, Type 2 Diabetes, Obesity
Interventions: WW Intervention, Usual Care; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 69 Years
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Stanford, California • Baton Rouge, Louisiana • Winston-Salem, North Carolina

Conditions: Healthy
Interventions: free-fall; Procedure
Lead sponsor: National Aeronautics and Space Administration (NASA); Federal
Eligibility: 25 Years to 55 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Breast Neoplasms
Interventions: MEDI4736; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Post-Dural Puncture Headache
Interventions: Lidocaine HCl Gel 2%, placebo gel; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 50 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Osteoarthritis, Knee
Interventions: Amniotic Fluid, Saline Placebo; Other
Lead sponsor: MiMedx Group, Inc.; Industry
Eligibility: 30 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 4
States / cities: Birmingham, Alabama • Atlanta, Georgia • Des Plaines, Illinois + 1 more

Conditions: Non-small Cell Lung Cancer, Colorectal Cancer, Breast Cancer
Interventions: Guardant360; Diagnostic Test
Lead sponsor: Guardant Health, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 470 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Skokie, Illinois

Conditions: Infertility
Interventions: MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL, MENOPUR powder and solvent for solution for injection, 75 IU, Placebo (for MENOPUR solution for injection in pre-filled pen), Placebo (for MENOPUR powder and solvent for solution for injection); Drug · Other
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 405 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 20
States / cities: Tempe, Arizona • San Diego, California • Farmington, Connecticut + 17 more

Conditions: Clostridium Difficile Infection
Interventions: Comparison between GenePOC PCR and Reference Method; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: Not listed
Enrollment: 2,461 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 5
States / cities: Indianapolis, Indiana • Baltimore, Maryland • Detroit, Michigan + 2 more

Conditions: Diabetes, Diabetes Mellitus
Interventions: Blood draw; Biological
Lead sponsor: MidAtlantic Retina; Other
Eligibility: 18 Minutes and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Advanced Solid Tumors
Interventions: LCL161; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 3
States / cities: Chapel Hill, North Carolina • Philadelphia, Pennsylvania • Nashville, Tennessee

Conditions: Inflammatory Myelopathies
Interventions: FES Cycling, Cycling without FES, Lumbar puncture, Mood assessment; Device · Procedure · Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2019
U.S. locations: 1
States / cities: Lutherville, Maryland

Conditions: TMJ - Oral &Maxillofacial Surgery, Oral and Maxillofacial Conditions, TMJ Pain, TMJ Arthralgia
Interventions: Bone Marrow Aspirate Concentrate, Corticosteroid (CS); Biological · Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Weight Loss, Delayed Gastric Emptying Following Procedure, Obesity, Mild, Obesity, Morbid, Obesity; Excess Calories
Interventions: Bariatric Endoscopic Antral Myotomy; Procedure
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cognitive Impairment
Interventions: Speed of Processing Training, Transfer Package from CI Therapy; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Weight Loss, Starvation
Interventions: Caloric Restriction, Protein, Exercise, Calcium and Vitamin D, Maltodextrin; Other · Dietary Supplement
Lead sponsor: University of Nebraska Lincoln; Other
Eligibility: 19 Years to 30 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Osteo Arthritis Knee
Interventions: Amniotic Fluid Injection, Standard of Care; Biological · Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Alzheimer's Disease
Interventions: AC-1204, Placebo; Drug
Lead sponsor: Cerecin; Industry
Eligibility: 66 Years to 90 Years
Enrollment: 418 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 82
States / cities: Birmingham, Alabama • Phoenix, Arizona • Hot Springs, Arkansas + 69 more

Conditions: Craniosynostoses
Interventions: MRI,DTI, functional MRI; Diagnostic Test
Lead sponsor: University of Arkansas; Other
Eligibility: Up to 4 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Arteriovenous Malformations
Interventions: Apollo™ Onyx™ Delivery Micro Catheter; Device
Lead sponsor: Medtronic Neurovascular Clinical Affairs; Industry
Eligibility: Not listed
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 2
States / cities: Englewood, Colorado • Boston, Massachusetts

Conditions: Cognitive Ability, General
Interventions: Cognitive Training - 48 sessions, Fitness, Active Control, active tDCS, sham tDCS, Cognitive Training - 20 sessions; Behavioral · Device
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 44 Years
Enrollment: 521 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Perforated Appendicitis
Interventions: PVI, Usual Care; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 346 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Recurrent Ovarian Cancer, Fallopian Tube Cancer
Interventions: Cisplatin, Doxorubicin; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Abnormal Labor, Failed Induction of Labor, Ketosis
Interventions: Accel Gel, Usual clear diet; Dietary Supplement
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Lymphedema, Breast Cancer
Interventions: Manual lymphatic drainage therapy; Procedure
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Nashville, Tennessee

Search by objective public record fields.

Improving Glycemic Control Using a Virtual Weight Control Program and Continuous Glucose Monitoring

Determining the Dose Response Profile of the Headward Fluid Shift During Varying Gravity Levels

Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer

RCT of SPG Blocks for Post-dural Headache

Protocol for the Clinical Evaluation of Lyophilized Amniotic Fluid in the Treatment of Knee Osteoarthritis

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)

Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains

Thrombospondin-1 and Pigmented Epithelium Derived Factor Levels in Patients With Diabetes Mellitus.

Safety and Efficacy of LCL161 in Patients With Solid Tumors

CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies

Biologic Augmentation of TMJ Arthroscopy Using BMAC

Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for Obesity

Improving Thinking in Everyday Life: Pilot Study A

Effect of Caloric Restriction and Protein Intake on Metabolism and Anabolic Sensitivity

pAF for the Treatment of Osteoarthritis

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext

Neurodevelopmental Outcomes in Craniosynostosis Repair

Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study

INSIGHT, A Comprehensive, Multidisciplinary Brain Training System

APPI-Cost Trial for Perforated Appendicitis

A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers

Enhanced vs. Routine Clear Liquid Intake in Labor

Lymphedema Progression Screening Using MRI